Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 0 | 29 | 209 | 482 | 294 |
| Gross Profit | N/A | 29 | 209 | 482 | 294 |
| Operating Expenses | 27,437 | 20,279 | 19,898 | 12,727 | 25,876 |
| Operating Income | -27,437 | -20,250 | -19,689 | -12,245 | -25,582 |
| Interest Expense | 25 | 0 | 0 | 0 | 0 |
| Other Income | 1,496 | 84 | -372 | 672 | 709 |
| Pre-tax Income | -25,966 | -20,166 | -20,061 | -11,573 | -24,873 |
| Net Income Continuous | -25,966 | -20,166 | -20,061 | -11,573 | -24,873 |
| Net Income | $-25,966 | $-20,166 | $-20,061 | $-11,573 | $-24,873 |
| EPS Basic Total Ops | -0.38 | -0.38 | -0.43 | -0.34 | -1.09 |
| EPS Basic Continuous Ops | -0.38 | -0.38 | -0.43 | -0.34 | -1.09 |
| EPS Diluted Total Ops | -0.38 | -0.38 | -0.43 | -0.34 | -1.09 |
| EPS Diluted Continuous Ops | -0.38 | -0.38 | -0.43 | -0.34 | -1.09 |
| EBITDA(a) | $-27,431 | $-20,240 | $-19,677 | $-12,232 | $-25,568 |